Genetic immune disorder innovation creating infrastructure — Wiskott-Aldrich syndrome treatments providing gene therapy and supportive management addressing immune deficiency and bleeding tendency, establishing WAS therapy as essential rare disease infrastructure, with the Wiskott-Aldrich Syndrome Treatment Market experiencing expansion driven by rare disease focus, gene therapy...